首页 | 本学科首页   官方微博 | 高级检索  
     

黄芪总皂苷调节环状RNA34116表达阻止肝纤维化进展
引用本文:周玉平,杨萍,唐春兰,璩辉,吕雪幼,胡桂梅. 黄芪总皂苷调节环状RNA34116表达阻止肝纤维化进展[J]. 温州医科大学学报, 2019, 49(4): 263-266
作者姓名:周玉平  杨萍  唐春兰  璩辉  吕雪幼  胡桂梅
作者单位:1.宁波大学医学院附属医院消化内科,浙江宁波315020;2.宁波卫生职业技术学院护理学院,浙江宁波315100;3.宁波大学医学院预防医学系,浙江宁波315211
基金项目:浙江省自然科学基金资助项目(LY18H270003);浙江省中医药科技计划项目(2019ZB114);宁波市自然科学基金资助项目(2018A610417)。
摘    要:目的:探讨黄芪总皂苷(AST)对肝纤维化模型的干预作用,并从环状RNA(circRNA)的角度分析其作用机制。方法:小鼠随机分为正常组、CCl4模型组、CCl4+AST组、CCl4+索拉菲尼组,每组8只。制备CCl4小鼠肝纤维化模型,给予AST和索拉菲尼干预后,用生化试剂盒检测血清肝功能,制作石蜡切片观察肝组织病理学变化(HE染色、Masson染色),RT-PCR检测各组环状RNA34116(mmu_circ_34116)表达变化。结果:组织病理检测显示,与正常组比较,CCl4模型组肝组织炎症反应和胶原表达显著增加;AST、索拉菲尼干预后,肝组织炎症显著减轻,胶原表达显著减少(P<0.05);血清肝功能检测显示,与正常组比较,CCl4模型组血清ALT、TBIL水平显著上升(P<0.01);AST、索拉菲尼干预后ALT、TBIL水平显著下降(P<0.01);RT-PCR检测结果显示,与正常组比较,CCl4模型组肝组织mmu_circ_34116表达量显著降低(P<0.01);AST干预可显著增加mmu_circ_34116的表达量(P<0.01);而索拉菲尼对mmu_circ_34116的表达量无显著影响(P>0.05)。结论:AST显著阻止肝纤维化模型的肝纤维化进展,其机制可能与调节mmu_circ_34116表达有关。

关 键 词:黄芪总皂苷  肝纤维化  mmu_circ_34116  小鼠  
收稿时间:2018-11-01

Study of anti-liver fibrosis effect of astralosides via circular RNA34116
ZHOU Yuping,YANG Ping,TANG Chunlan,QU Hui,LYU Xueyou,HU Guimei. Study of anti-liver fibrosis effect of astralosides via circular RNA34116[J]. JOURNAL OF WENZHOU MEDICAL UNIVERSITY, 2019, 49(4): 263-266
Authors:ZHOU Yuping  YANG Ping  TANG Chunlan  QU Hui  LYU Xueyou  HU Guimei
Affiliation:1.Department of Gastroenterology, the Affiliated Hospital of Medical School of Ningbo University, Ningbo 315020, China; 2.School of Nursing, Ningbo College of Health Sciences, Ningbo 315100, China; 3.Department of Preventive Medicine, Medical School of Ningbo University, Ningbo 315211, China
Abstract:Objective: To study the mechanism underlying Astragalosides in the inhibition of hepatic fibrosis via circularRNA. Methods: Mice were randomly divided as normal group, CCl4 model group, Astragalosides group and sorafenib group, with 8 mice in each group. A CCl4 liver fibrosis model was established. After drug intervention with Astragalosides, the serum ALT and TBIL, pathological changes (HE staining and Masson staining) of the liver and relative mmu_circ_34116 expressionwere detected and observed by RT-PCR. Results: Histopathological results showed that, compared with the normal group, liver tissue inflammation and collagen deposition were significantly increased Astragalosides and sorafenib significantly reduced inflammation and collagen deposition. The results of serum liver function showed that Astragalosides and sorafenib significantly reduced the level of ALT and TBIL after intervention in the model mice. RT-PCR results showed that, compared with the normal group, the expression of mmu_circ_34116 in liver tissue was significantly reduced in CCl4 model group, and its expression was significantly increased after intervention with Astragalosides in the model, but sorafenib had no significant effect on its expression. Conclusion: Astragalosides significantly inhibited the development of liver fibrosis. The mechanism may be associated with over expression of mmu_circ_34116.
Keywords:astragalosides  liver fibrosis  mmu_circ_34116  mice  
点击此处可从《温州医科大学学报》浏览原始摘要信息
点击此处可从《温州医科大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号